Highlights

Highlights

  • 12.02.2026 – 11:00

    SolidarMed

    SolidarMed: High blood pressure: trained laypeople improve healthcare in rural Africa

    High blood pressure: trained laypeople improve healthcare in rural Africa

    Basel (ots) - In rural regions of Africa, high blood pressure often goes untreated because health centres are far away and there is a shortage of health professionals. A study by the University of Basel and SolidarMed in Lesotho shows that, with the help of a tablet app, villagers who have received training achieve better blood pressure control in their village community compared to normal treatment in healthcare facilities. The results provide the first robust data for an approach that could significantly improve access to blood pressure treatment in underserved regions. High blood pressure ...

Neueste Storys

Filtern
  • 24.01.2019 – 14:01

    Merck Healthcare Germany

    Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors

    Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - Exclusive license grants Vertex one clinical and one pre-clinical DNA-PK inhibitor for use in gene-editing applications in six specific genetic disease areas - Merck retains the rights to both compounds in all other disease areas, including oncology - Merck retains the rights to utilize and ...

  • 23.01.2019 – 16:02

    Philogen

    Philogen Announces Collaboration With Celgene

    Siena, Italy (ots/PRNewswire) - Philogen S.p.A. (a privately-owned company) today announced that they have entered into a collaboration and license agreement with Celgene, to discover and develop a new class of immunomodulatory therapeutics. (Logo: https://mma.prnewswire.com/media/811555/Philogen_Logo.jpg ) "We are extremely pleased to establish a new collaboration with Celgene, a leader in the discovery and development ...

  • 23.01.2019 – 16:01

    Philogen

    Philogen Announces Collaboration

    Siena, Italy (ots/PRNewswire) - Philogen S.p.A. (a privately-owned company) today announced that they have entered into a collaboration and license agreement with Novartis to discover and develop a new class of immunomodulatory therapeutics. (Logo: https://mma.prnewswire.com/media/811555/Philogen_Logo.jpg ) "We are extremely pleased to establish a new collaboration with Novartis, a leader in the discovery and development of therapies for cancer patients," commented Dr. ...

  • 23.01.2019 – 15:34

    Schweizerischer Nationalfonds / Fonds national suisse

    Young adults caught in a dilemma between traditional family models and modern views

    Bern (ots) - A study funded by the Swiss National Science Foundation has found that even young adults who do not yet have children are influenced by traditional concepts of family. At the same time, they have modern views of equality, career engagement and childcare. The result is a dilemma that affects not only young women, but also young men early in adulthood. ...